✦ LIBER ✦

Adjuvant chemotherapy in gastric cancer

✍ Scribed by Peter Schlag

Publisher: Springer
Year: 1987
Tongue: English
Weight: 577 KB
Volume: 11
Category: Article
ISSN: 0364-2313
DOI: 10.1007/bf01655812

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose intensity of mitomycin C in adjuvan

Dose intensity of mitomycin C in adjuvant cancer chemotherapy for patients with gastric cancer

✍ Tetsuro Kubota; Koichiro Kumai; Masaki Kitajima; Osahiko Abe; Masato Fujisaki; Y 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Using a cohort of macroscopic curative resections of gastric cancer at stages 11, Ill, and IV, a randomized controlled trial was performed to clucidate the dose efficacy of intensive adjuvant cancer chemotherapy with mitomycin C. Between June 1983 and December 1986, 336 patients with gastric cancer

Impact of adjuvant chemotherapy in the l

Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer

✍ Juan J. Grau; Marta Martín; José Fuster; Manuel Pera; Juan C. García-Valdecasas; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

An interim report of a prospective, rand

An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British stomach cancer group

✍ J. W. L. Fielding; S. L. Fagg; B. G. Jones; D. Ellis; M. S. Hockey; A. Minawa; V 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 951 KB

Dihydropyrimidine dehydrogenases and cyt

Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy

✍ Juan J. Grau; Miguel Caballero; Mariano Monzó; Carmen Muñoz-García; Jose Domingo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

HIF-1α is an unfavorable determinant of

HIF-1α is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy

✍ Jun Nakamura; Yoshihiko Kitajima; Keita Kai; Kazuyoshi Hashiguchi; Masatsugu Hir 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 707 KB

## Abstract Among several chemotherapeutic agents, 5‐fluorouracil (5‐FU) has been widely used as a key drug in adjuvant chemotherapy for gastric cancer. However, no reliable marker, which predicts the response to 5‐FU in an adjuvant setting, has been identified. Hypoxia‐induced drug resistance, __v

N1-(2 tetrahydrofuryl)-5-fluorouracil (f

N1-(2 tetrahydrofuryl)-5-fluorouracil (ft-207) in the postoperative adjuvant chemotherapy of gastric cancer. Delivery of a fat-emulsified agent to the lymph

✍ Hitoshi Hanaue; Tsutomu Kurosawa; Yoshiaki Kitano; Sadaaki Miyakawa; Fumitoshi H 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB